Meet
Features
Solutions
Pricing
Sales Intelligence
Qualify prospects and connect with decision makers effortlessly
Research Companies & Directors
Make important decisions with absolute confidence
Create B2B Marketing Lists
Target and reach more of your ideal prospects than ever
Monitor Risks & Opportunities
Be the first to learn about changes in the companies that matter
Cleanse Your B2B Database
Instantly transform old records into new opportunities
Perform KYC Checks
Completely understand who you're working with
Discover New Businesses
Identify and connect with new companies as soon as they register
Company Credit Reports
See how companies are performing year–on–year and explore their debts
UPGRADE
Contact
Credit Report
Financials
People
Ownership
Latest Activity
Mutual Companies
Documents
Repayment History
Oxford Cancer Biomarkers Limited
Oxford Cancer Biomarkers Limited is an active company incorporated on 24 May 2010 with the registered office located in Kilmacolm, Renfrewshire. Oxford Cancer Biomarkers Limited was registered 15 years ago.
Watch Company
Status
Active
Active since
13 years ago
Company No
SC379069
Private limited company
Scottish Company
Age
15 years
Incorporated
24 May 2010
Size
Micro
Turnover is under
£1M
Balance sheet is under
£500,000
Under
10 employees
Confirmation
Submitted
Dated
23 December 2024
(10 months ago)
Next confirmation dated
23 December 2025
Due by
6 January 2026
(1 month remaining)
Last change occurred
10 months ago
Accounts
Submitted
For period
1 Jan
⟶
31 Dec 2024
(1 year)
Accounts type is
Total Exemption Full
Next accounts for period
31 December 2025
Due by
30 September 2026
(10 months remaining)
Learn more about Oxford Cancer Biomarkers Limited
Contact
Update Details
Address
C/O Douglas Mcdonald Ca
2 Octavia Buildings
Kilmacolm
PA13 4AE
Same address since
incorporation
Companies in PA13 4AE
Telephone
01865784743
Email
Unreported
Website
Oxfordcancerbiomarkers.com
See All Contacts
People
Officers
4
Shareholders
21
Controllers (PSC)
1
Prof Nicholas Barrie La Thangue
Director • British • Lives in UK • Born in Nov 1957
Professor David James Kerr
Director • British • Lives in England • Born in Jun 1956
Mohammed Jamal
Director • British • Lives in England • Born in Jan 1980
Bungkwn Lee
Director • South Korean • Lives in South Korea • Born in Apr 1960
PSC
See Key People
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
See All Shareholders, PSCs & Group Structure
Mutual Companies
Celleron Therapeutics Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
MJ & Family UK Limited
Mohammed Jamal is a mutual person.
Active
Argonaut Therapeutics Limited
Prof Nicholas Barrie La Thangue is a mutual person.
Active
MJF Friendlyscore SPV Limited
Mohammed Jamal is a mutual person.
Active
SSF SPV Limited
Mohammed Jamal is a mutual person.
Active
Exen Capital Advisors Ltd
Mohammed Jamal is a mutual person.
Active
MJ Family Group Ltd
Mohammed Jamal is a mutual person.
Active
Double I Delices Ltd
Mohammed Jamal is a mutual person.
Active
See All Mutual Companies
Brands
Oxford Cancer Biomarkers
Oxford Cancer Biomarkers develops cancer biomarker technology to support clinical decision-making.
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
31 Dec 2024
For period
31 Dec
⟶
31 Dec 2024
Traded for
12 months
Cash in Bank
£31K
Decreased by £107K (-78%)
Turnover
Unreported
Same as previous period
Employees
2
Decreased by 6 (-75%)
Total Assets
£376K
Decreased by £147K (-28%)
Total Liabilities
-£374K
Decreased by £186K (-33%)
Net Assets
£2K
Increased by £39K (-105%)
Debt Ratio (%)
99%
Decreased by 7.61% (-7%)
See 10 Year Full Financials
Latest Activity
Full Accounts Submitted
8 Months Ago on 11 Mar 2025
Confirmation Submitted
10 Months Ago on 2 Jan 2025
Full Accounts Submitted
1 Year 4 Months Ago on 26 Jun 2024
Kyoung Mee Lee Resigned
1 Year 6 Months Ago on 23 Apr 2024
Professor David James Kerr Appointed
1 Year 6 Months Ago on 17 Apr 2024
Full Accounts Submitted
1 Year 9 Months Ago on 6 Feb 2024
Confirmation Submitted
1 Year 10 Months Ago on 2 Jan 2024
Dean Marc Slagel Resigned
1 Year 11 Months Ago on 22 Nov 2023
Joanna Smart Resigned
2 Years 1 Month Ago on 13 Sep 2023
Christopher Malcolm Towler Resigned
2 Years 5 Months Ago on 16 May 2023
Get Alerts
Get Credit Report
Discover Oxford Cancer Biomarkers Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
See All Credit Score & Limits
Documents
Total exemption full accounts made up to 31 December 2024
Submitted on 11 Mar 2025
Confirmation statement made on 23 December 2024 with updates
Submitted on 2 Jan 2025
Statement of capital following an allotment of shares on 3 June 2024
Submitted on 28 Jun 2024
Statement of capital following an allotment of shares on 3 June 2024
Submitted on 27 Jun 2024
Total exemption full accounts made up to 31 December 2023
Submitted on 26 Jun 2024
Termination of appointment of Kyoung Mee Lee as a director on 23 April 2024
Submitted on 23 Apr 2024
Appointment of Professor David James Kerr as a director on 17 April 2024
Submitted on 18 Apr 2024
Resolutions
Submitted on 26 Mar 2024
Total exemption full accounts made up to 31 December 2022
Submitted on 6 Feb 2024
Confirmation statement made on 23 December 2023 with updates
Submitted on 2 Jan 2024
Explore All Documents
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year
See All Charges & CCJs